{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:52:23Z","timestamp":1781869943994,"version":"3.54.5"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To review diagnostic approaches and treatment thresholds for presumed tuberculous uveitis when ocular inflammation is the only manifestation of tuberculosis (TB), focusing on phenotype-based risk stratification, interferon-gamma release assay (IGRA) interpretation, mimic exclusion, and evidence for antitubercular therapy (ATT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Narrative review using targeted PubMed search of ocular TB literature. Search terms included \u201cocular tuberculosis\u201d, \u201ctuberculous uveitis\u201d, specific phenotypes (serpiginous-like choroiditis, retinal vasculitis, tuberculoma), and treatment outcomes. We prioritized consensus guidelines, systematic reviews, meta-analyses, and randomized data. Findings were synthesized into a phenotype-anchored diagnostic and treatment algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ocular TB is usually diagnosed through a comprehensive assessment of ocular phenotype, epidemiologic risk, systemic evaluation, TB immunologic testing, and mimic exclusion. Higher-suspicion phenotypes include serpiginous-like choroiditis, occlusive retinal vasculitis, choroidal tuberculoma, anterior uveitis with iris nodules, and chronic granulomatous anterior uveitis in the appropriate clinical context. IGRA results support prior TB sensitization but do not establish ocular causality; positive results may be incidental, particularly in low-burden settings, while negative results do not fully exclude ocular TB when phenotype and epidemiologic context are strongly suggestive. Consensus guidance and recent randomized evidence support ATT in selected patients, but treatment thresholds remain phenotype- and context-dependent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compatible ocular phenotypes should prompt TB-directed evaluation, including IGRA and systemic assessment, with immunologic testing interpreted as supportive evidence. Treatment decisions should consider phenotype, epidemiological risk, mimic exclusion, and consequences of delayed treatment. High-risk presentations may justify lower treatment thresholds, while nonspecific ocular findings with isolated immunologic positivity should prompt consideration of alternative diagnoses or LTBI management according to local guidance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10792-026-04134-3","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:13:12Z","timestamp":1781863992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds"],"prefix":"10.1007","volume":"46","author":[{"given":"Sedra T.","family":"Alabed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"4134_CR1","volume-title":"Clinical Manifestations, in Tuberculosis in Adults and Children","author":"D Heemskerk","year":"2015","unstructured":"Heemskerk D, Caws M, Marais B (2015) Clinical Manifestations, in Tuberculosis in Adults and Children. Springer, London"},{"issue":"8","key":"4134_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11274-023-03636-x","volume":"39","author":"ML Carabal\u00ed-Isajar","year":"2023","unstructured":"Carabal\u00ed-Isajar ML et al (2023) Clinical manifestations and immune response to tuberculosis. World J Microbiol Biotechnol 39(8):206","journal-title":"World J Microbiol Biotechnol"},{"issue":"6","key":"4134_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/ICU.0000000000000991","volume":"34","author":"B Bates","year":"2023","unstructured":"Bates B, Crowell EL (2023) Ophthalmic manifestations of tuberculosis. Curr Opin Ophthalmol 34(6):529\u2013534","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"4134_CR4","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.4103\/ijo.IJO_1451_20","volume":"68","author":"I Testi","year":"2020","unstructured":"Testi I et al (2020) Ocular tuberculosis: Where are we today? Indian Journal of Ophthalmology. 68(9):1808\u20131817","journal-title":"Indian Journal of Ophthalmology."},{"issue":"9","key":"4134_CR5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.18240\/ijo.2022.09.16","volume":"15","author":"U Tungsattayathitthan","year":"2022","unstructured":"Tungsattayathitthan U et al (2022) Interferon-gamma release assays in tuberculous uveitis: a comprehensive review. Int J Ophthalmol 15(9):1520\u20131528","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"4134_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00004397-200004000-00011","volume":"40","author":"SR Rathinam","year":"2000","unstructured":"Rathinam SR, Cunningham ET Jr (2000) Infectious causes of uveitis in the developing world. Int Ophthalmol Clin 40(2):137\u2013152","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"4134_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/IIO.0b013e3181d2ccb9","volume":"50","author":"AM Abu El-Asrar","year":"2010","unstructured":"Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS (2010) Tuberculous uveitis. Int Ophthalmol Clin. 50(2):19\u201339","journal-title":"Int Ophthalmol Clin."},{"issue":"7","key":"4134_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.ophtha.2009.02.005","volume":"116","author":"M Ang","year":"2009","unstructured":"Ang M, Htoon HM, Chee SP (2009) Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology 116(7):1391\u20131396","journal-title":"Ophthalmology"},{"issue":"3","key":"4134_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.survophthal.2021.10.001","volume":"67","author":"HD Alli","year":"2022","unstructured":"Alli HD et al (2022) Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol 67(3):770\u2013792","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"4134_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12879-024-10288-1","volume":"25","author":"JW Taylor","year":"2025","unstructured":"Taylor JW et al (2025) A systemic review of the utility of antituberculosis therapy for presumed tuberculous uveitis. BMC Infect Dis 25(1):112","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4134_CR11","first-page":"1173","volume":"149","author":"JT Rosenbaum","year":"1989","unstructured":"Rosenbaum JT (1989) Uveitis. An internist\u2019s view Arch Intern Med 149(5):1173\u20131176","journal-title":"An internist's view Arch Intern Med"},{"issue":"11","key":"4134_CR12","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3390\/jcm12113746","volume":"12","author":"R Jacquot","year":"2023","unstructured":"Jacquot R et al (2023) Diagnosis, Classification, and Assessment of the Underlying Etiology of Uveitis by Artificial Intelligence: A Systematic Review. J Clin Med 12(11):3746","journal-title":"J Clin Med"},{"issue":"6","key":"4134_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/ceo.13517","volume":"47","author":"CT Hart","year":"2019","unstructured":"Hart CT et al (2019) Epidemiology of uveitis in urban Australia. Clin Exp Ophthalmol 47(6):733\u2013740","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"4134_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","volume":"80","author":"B Bodaghi","year":"2001","unstructured":"Bodaghi B et al (2001) Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 80(4):263\u2013270","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4134_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001225","volume":"9","author":"OM Kon","year":"2022","unstructured":"Kon OM et al (2022) BTS clinical statement for the diagnosis and management of ocular tuberculosis. BMJ Open Respir Res 9(1):e001225","journal-title":"BMJ Open Respir Res"},{"issue":"7","key":"4134_CR16","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.7150\/thno.81488","volume":"13","author":"Z Ludi","year":"2023","unstructured":"Ludi Z et al (2023) Diagnosis and biomarkers for ocular tuberculosis: From the present into the future. Theranostics 13(7):2088\u20132113","journal-title":"Theranostics"},{"issue":"6","key":"4134_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamaophthalmol.2013.71","volume":"131","author":"SS Patel","year":"2013","unstructured":"Patel SS et al (2013) Mycobacterial Ocular Inflammation: Delay in Diagnosis and Other Factors Impacting Morbidity. JAMA Ophthalmolo 131(6):752\u2013758","journal-title":"JAMA Ophthalmolo"},{"key":"4134_CR18","unstructured":"Sallam, A., S. Karimaghaei, and A.J. Neuhouser, 2025 Ocular Tuberculosis, in StatPearls [Internet]. StatPearls Publishing: Treasure Island (FL)."},{"issue":"2","key":"4134_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw694","volume":"64","author":"DM Lewinsohn","year":"2016","unstructured":"Lewinsohn DM et al (2016) Official american thoracic society\/infectious diseases society of America\/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 64(2):e1\u2013e33","journal-title":"Clin Infect Dis"},{"key":"4134_CR20","unstructured":"Control, C.f.D. and Prevention. Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay. 2024 2024\/05\/09; 2026\/01\/29:[Available from: https:\/\/www.cdc.gov\/tb\/hcp\/testing-diagnosis\/interferon-gamma-release-assay.html."},{"issue":"3","key":"4134_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10067-026-07932-3","volume":"45","author":"FM Ko\u00e7ak","year":"2026","unstructured":"Ko\u00e7ak FM, Yarg\u0131 \u00d6zko\u00e7ak B (2026) Minimizing missed latent tuberculosis infection under adalimumab: real-world data from a BCG-vaccinated cohort. Clinical Rheumatology 45(3):1657\u20131665","journal-title":"Clinical Rheumatology"},{"key":"4134_CR22","doi-asserted-by":"crossref","unstructured":"Collaborative Ocular Tuberculosis Study Consensus, G., et al., 2021 Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis. 2014;Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis. Ophthalmology,. 128(2): 277\u2013287.","DOI":"10.1016\/j.ophtha.2021.03.024"},{"issue":"2","key":"4134_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.survophthal.2022.10.001","volume":"68","author":"BK Betzler","year":"2023","unstructured":"Betzler BK et al (2023) Anti-tubercular therapy in the treatment of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol 68(2):241\u2013256","journal-title":"Surv Ophthalmol"},{"key":"4134_CR24","volume":"35","author":"Y Ngathaweesuk","year":"2024","unstructured":"Ngathaweesuk Y, Janthayanont S, Keorochana N (2024) Characteristics and outcomes of the duration of treatment with adjunctive corticosteroids in intraocular tuberculosis. J Clinical Tuber Mycobact Dis 35:100439","journal-title":"J Clinical Tuber Mycobact Dis"},{"key":"4134_CR25","doi-asserted-by":"crossref","unstructured":"Filardo T.D., et al., 2024 Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993\u20132019. Open Forum Infect Dis. 11(9) ofae476.","DOI":"10.1093\/ofid\/ofae476"},{"key":"4134_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajo.2021.03.040","volume":"228","author":"Classification Criteria for Tubercular Uveitis","year":"2021","unstructured":"Classification Criteria for Tubercular Uveitis (2021) Am J Ophthalmol 228:142\u2013151","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4134_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/09273948.2025.2590716","volume":"34","author":"H Amin","year":"2026","unstructured":"Amin H, Shoughy S (2026) Presumed ocular tuberculosis: insights from an egyptian cohort. Ocul Immunol Inflamm 34(1):56\u201363","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"4134_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1128\/microbiolspec.tnmi7-0001-2016","volume":"4","author":"M Albert Daniel","year":"2016","unstructured":"Albert Daniel M, Raven Meisha L (2016) Ocular Tuberculosis. Microbio Spectrum 4(6):313\u2013330. https:\/\/doi.org\/10.1128\/microbiolspec.tnmi7-0001-2016","journal-title":"Microbio Spectrum"},{"issue":"1","key":"4134_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1869-5760-4-10","volume":"4","author":"PK Balne","year":"2014","unstructured":"Balne PK et al (2014) Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthalmic Inflamm Infecti 4(1):10","journal-title":"J Ophthalmic Inflamm Infecti"},{"issue":"4","key":"4134_CR30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ajo.2013.12.021","volume":"157","author":"KL Pepple","year":"2014","unstructured":"Pepple KL, Van Gelder R, Forooghian F (2014) Caveats about QuantiFERON\u2013TB gold in-tube testing for uveitis. Am J Ophthalmol 157(4):752\u2013753","journal-title":"Am J Ophthalmol"},{"key":"4134_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajo.2019.11.009","volume":"211","author":"F Groen-Hakan","year":"2020","unstructured":"Groen-Hakan F et al (2020) Prevalence of positive QuantiFERON-TB Gold In-tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis. Am J Ophthalmol 211:151\u2013158","journal-title":"Am J Ophthalmol"},{"key":"4134_CR32","first-page":"14","volume":"263","author":"P Lin","year":"2024","unstructured":"Lin P (2024) Diagnostic utility of QuantiFERON-Gold testing in patients with ocular inflammation in a low-endemic tuberculosis region. Am J Ophthalmol 263:14\u201320","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4134_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000663","volume":"6","author":"S Rahman","year":"2021","unstructured":"Rahman S, Irfan M, Siddiqui MAR (2021) Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review. BMJ Open Ophthalmology 6(1):e000663","journal-title":"BMJ Open Ophthalmology"},{"issue":"1","key":"4134_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12886-017-0597-x","volume":"17","author":"R Agrawal","year":"2017","unstructured":"Agrawal R et al (2017) What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis. BMC Ophthalmol 17(1):245","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"4134_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3341\/kjo.2014.28.3.226","volume":"28","author":"SJ Ahn","year":"2014","unstructured":"Ahn SJ et al (2014) The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea. Korean J Ophthalmol 28(3):226\u2013233","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"4134_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/IAE.0000000000002915","volume":"41","author":"A Agarwal","year":"2021","unstructured":"Agarwal A et al (2021) Longitudinal follow-up of tubercular serpiginous-like choroiditis using optical coherence tomography angiography. Retina 41(4):793\u2013803","journal-title":"Retina"},{"issue":"1","key":"4134_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/ijo.IJO_78_19","volume":"68","author":"M Brar","year":"2020","unstructured":"Brar M et al (2020) Comparison of wide-field swept source optical coherence tomography angiography and fundus autofluorescence in tubercular serpiginous-like choroiditis. Indian J Ophthalmol 68(1):106\u2013211","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"4134_CR38","first-page":"327","volume":"31","author":"WX Na","year":"2018","unstructured":"Na WX et al (2018) Optical coherence tomography features of tuberculous serpiginous-like choroiditis and serpiginous choroiditis. Biomedical and Environmental Sciences. 31(5):327","journal-title":"Biomedical and Environmental Sciences."},{"key":"4134_CR39","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.2147\/OPTH.S284613","volume":"15","author":"D Shukla","year":"2021","unstructured":"Shukla D, Kalliath J, Dhawan A (2021) Tubercular Retinal Vasculitis: Diagnostic Dilemma and Management Strategies. Clin Ophthalmol 15:4681\u20134688","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"4134_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/biology13060460","volume":"13","author":"K Bae","year":"2024","unstructured":"Bae K et al (2024) A review of eales disease and mycobacterium tuberculosis. Biology. 13(6):460","journal-title":"Biology."},{"key":"4134_CR41","doi-asserted-by":"crossref","unstructured":"Patricio, M.S., et al., 2013 Tubercular retinal vasculitis. BMJ Case Rep.","DOI":"10.1136\/bcr-2013-008924"},{"issue":"3","key":"4134_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/jpm14030235","volume":"14","author":"MF Mercu\u021b","year":"2024","unstructured":"Mercu\u021b MF et al (2024) A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature. Journal of Personalized Medicine 14(3):235","journal-title":"Journal of Personalized Medicine"},{"issue":"4","key":"4134_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0974-9233.58423","volume":"16","author":"AM Abu El-Asrar","year":"2009","unstructured":"Abu El-Asrar AM, Herbort CP, Tabbara KF (2009) Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol 16(4):202\u201318","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"10","key":"4134_CR44","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/medicina58101467","volume":"58","author":"PP Meng","year":"2022","unstructured":"Meng PP et al (2022) Use of ultra-widefield fluorescein angiography to guide the treatment to idiopathic retinal vasculitis, aneurysms, and neuroretinitis-case report and literature review. Medicina. 58(10):927","journal-title":"Medicina."},{"issue":"4","key":"4134_CR45","doi-asserted-by":"publisher","first-page":"e184499","DOI":"10.1001\/jamaophthalmol.2018.4499","volume":"137","author":"L Chen","year":"2019","unstructured":"Chen L (2019) Tubercular Retinal Vasculitis. JAMA Ophthalmology 137(4):e184499\u2013e184499","journal-title":"JAMA Ophthalmology"},{"issue":"3","key":"4134_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/tjo.tjo_115_17","volume":"8","author":"N-Y Hsia","year":"2018","unstructured":"Hsia N-Y et al (2018) Ultra-widefield angiography in the diagnosis and management of uveitis. Taiwan J Ophthalmol 8(3):159\u2013163","journal-title":"Taiwan J Ophthalmol"},{"issue":"5\u20136","key":"4134_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000541149","volume":"247","author":"A Arora","year":"2024","unstructured":"Arora A et al (2024) Diagnostic workup of retinal vasculitis: an algorithmic approach. Ophthalmol 247(5\u20136):280\u2013292","journal-title":"Ophthalmol"},{"key":"4134_CR48","doi-asserted-by":"crossref","unstructured":"Kumar, M., et al., Unilateral solitary choroidal tuberculoma as the presenting sign in disseminated tuberculosis in an immunocompetent patient. European Journal of Ophthalmology, 2024. 34(1): p. NP41-NP43.","DOI":"10.1177\/11206721231183019"},{"key":"4134_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2019.101580","volume":"29","author":"FE Aksoy","year":"2020","unstructured":"Aksoy FE, Altan C, Basarir B (2020) Multimodal imaging of a choroidal granuloma as a first sign of tuberculosis. Photodiagn Photodyn Ther 29:101580","journal-title":"Photodiagn Photodyn Ther"},{"issue":"4","key":"4134_CR50","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.4103\/ijo.IJO_2830_21","volume":"70","author":"GAD O'Keefe","year":"2022","unstructured":"O\u2019Keefe GAD, Rao NA (2022) Progress in the diagnosis of ocular sarcoidosis. Indian J Ophthalmol 70(4):1121\u20131129","journal-title":"Indian J Ophthalmol"},{"key":"4134_CR51","first-page":"13","volume":"7","author":"LA Dalvin","year":"2017","unstructured":"Dalvin LA, Smith WM (2017) Intraocular manifestations of mycobacterium tuberculosis: A review of the literature. J Clin Tuberc Mycobact Dis 7:13\u201321","journal-title":"J Clin Tuberc Mycobact Dis"},{"issue":"4","key":"4134_CR52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/ijo.IJO_464_16","volume":"65","author":"R Bansal","year":"2017","unstructured":"Bansal R et al (2017) Imaging in tuberculosis-associated uveitis. Indian J Ophthalmol 65(4):264\u2013270","journal-title":"Indian J Ophthalmol"},{"key":"4134_CR53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajo.2021.01.025","volume":"226","author":"A Agarwal","year":"2021","unstructured":"Agarwal A et al (2021) Clinical and multimodal imaging clues in differentiating between tuberculomas and sarcoid choroidal granulomas. Am J Ophthalmol 226:42\u201355","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4134_CR54","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/09273948.2025.2450473","volume":"33","author":"J Biju Mark","year":"2025","unstructured":"Biju Mark J et al (2025) Intermediate uveitis: an updated review of the differential diagnosis and relevant special investigations. Ocul Immunol Inflamm 33(4):522\u2013534","journal-title":"Ocul Immunol Inflamm"},{"key":"4134_CR55","unstructured":"American Academy of, O., Intermediate Uveitis. EyeWiki."},{"issue":"2","key":"4134_CR56","first-page":"237","volume":"24","author":"C Lee","year":"2016","unstructured":"Lee C, Agrawal R, Pavesio C (2016) Ocular Tuberculosis\u2013A Clinical Conundrum. Ocul Immunol Inflamm 24(2):237\u2013242","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"4134_CR57","doi-asserted-by":"publisher","first-page":"e993","DOI":"10.1016\/j.ijid.2013.03.019","volume":"17","author":"AG Vos","year":"2013","unstructured":"Vos AG et al (2013) Diagnosis and treatment of tuberculous uveitis in a low endemic setting. Int J Infect Dis 17(11):e993\u2013e999","journal-title":"Int J Infect Dis"},{"issue":"31","key":"4134_CR58","first-page":"352","volume":"8","author":"R Sharma","year":"2010","unstructured":"Sharma R, Marasini S, Nepal BP (2010) Tubercular scleritis. Kathmandu Univ Med J 8(31):352\u2013356","journal-title":"Kathmandu Univ Med J"},{"key":"4134_CR59","doi-asserted-by":"publisher","first-page":"1493831","DOI":"10.3389\/fopht.2025.1493831","volume":"5","author":"S Sharma","year":"2025","unstructured":"Sharma S, Sheth JU, Murthy SI (2025) Infectious scleritis: a review of etiologies, clinical features, and management strategies. Front Ophthalmol 5:1493831","journal-title":"Front Ophthalmol"},{"issue":"4","key":"4134_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/01676830802225152","volume":"27","author":"SN Madge","year":"2008","unstructured":"Madge SN et al (2008) Orbital tuberculosis: a review of the literature. Orbit 27(4):267\u2013277","journal-title":"Orbit"},{"issue":"25","key":"4134_CR61","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMra2216081","volume":"389","author":"ML Durand","year":"2023","unstructured":"Durand ML, Barshak MB, Sobrin L (2023) Eye Infections. N Engl J Med 389(25):2363\u20132375","journal-title":"N Engl J Med"},{"key":"4134_CR62","doi-asserted-by":"crossref","unstructured":"Expert Panel on Thoracic I, et al., 2017 ACR Appropriateness Criteria Imaging of&#xa;Possible Tuberculosis. Journal of the American College of Radiology. 14(5) S160-S165.","DOI":"10.1016\/j.jacr.2017.02.022"},{"issue":"1","key":"4134_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1148\/rg.2017160032","volume":"37","author":"AC Nachiappan","year":"2017","unstructured":"Nachiappan AC (2017) Pulmonary tuberculosis: role of radiology in diagnosis and management. Radiographics 37(1):52\u201372","journal-title":"Radiographics"},{"key":"4134_CR64","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/OPTH.S65254","volume":"9","author":"FI Shakarchi","year":"2015","unstructured":"Shakarchi FI (2015) Ocular tuberculosis: current perspectives. Clin Ophthalmol 9:2223\u20132227","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"4134_CR65","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/ijri.IJRI_200_17","volume":"27","author":"D Ganeshan","year":"2017","unstructured":"Ganeshan D (2017) Dilemma of diagnosing thoracic sarcoidosis in tuberculosis-endemic regions: An imaging-based approach. Part 1. Indian J Radiol Imag 27(4):369\u2013379","journal-title":"Indian J Radiol Imag"},{"issue":"11","key":"4134_CR66","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.5588\/ijtld.18.0013","volume":"22","author":"JA Shaw","year":"2018","unstructured":"Shaw JA et al (2018) Utility of routine chest radiography in ocular tuberculosis and sarcoidosis. Int J Tuberc Lung Dis 22(11):1374\u20131377","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"4134_CR67","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMra2308181","volume":"391","author":"G Meintjes","year":"2024","unstructured":"Meintjes G, Maartens G (2024) HIV-Associated Tuberculosis. N Engl J Med 391(4):343\u2013355","journal-title":"N Engl J Med"},{"issue":"9","key":"4134_CR68","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/jcm12093194","volume":"12","author":"S Giorgiutti","year":"2023","unstructured":"Giorgiutti S et al (2023) Sarcoidosis-Related Uveitis: A Review. J Clin Med 12(9):3195","journal-title":"J Clin Med"},{"issue":"7","key":"4134_CR69","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41433-022-02147-7","volume":"37","author":"R Agrawal","year":"2023","unstructured":"Agrawal R et al (2023) The collaborative ocular tuberculosis study (COTS) calculator-a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis. Eye (Lond) 37(7):1416\u20131423","journal-title":"Eye (Lond)"},{"issue":"12","key":"4134_CR70","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jamaophthalmol.2024.4567","volume":"142","author":"L Zhang","year":"2024","unstructured":"Zhang L et al (2024) Validation of the online collaborative ocular tuberculosis study calculator for tubercular uveitis. JAMA Ophthalmology 142(12):1140\u20131148","journal-title":"JAMA Ophthalmology"},{"issue":"5","key":"4134_CR71","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","volume":"61","author":"AR Kee","year":"2016","unstructured":"Kee AR et al (2016) Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis. Surv Ophthalmol 61(5):628\u2013653","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"4134_CR72","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2025.4358","volume":"334","author":"P Maghsoudlou","year":"2025","unstructured":"Maghsoudlou P et al (2025) Uveitis in Adults: A Review. JAMA 334(5):419\u2013434","journal-title":"JAMA"},{"issue":"12","key":"4134_CR73","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","volume":"135","author":"R Agrawal","year":"2017","unstructured":"Agrawal R et al (2017) Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)\u20131. JAMA Ophthalmology 135(12):1318\u20131327","journal-title":"JAMA Ophthalmology"},{"issue":"1","key":"4134_CR74","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bjophthalmol-2016-309531","volume":"101","author":"M Ang","year":"2017","unstructured":"Ang M, Chee SP (2017) Controversies in ocular tuberculosis. Br J Ophthalmol 101(1):6\u20139","journal-title":"Br J Ophthalmol"},{"key":"4134_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103511","volume":"88","author":"R La Distia Nora","year":"2025","unstructured":"La Distia Nora R et al (2025) Antitubercular therapy for uveitis of undetermined cause with positive interferon-gamma release assay: a single-blind, single-centre, phase 2 randomised controlled trial. EClinicalMedicine 88:103511","journal-title":"EClinicalMedicine"},{"issue":"6","key":"4134_CR76","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta V, Gupta A, Rao NA (2007) Intraocular tuberculosis\u2013an update. Surv Ophthalmol 52(6):561\u2013587","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"4134_CR77","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ (2006) An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 174(8):935\u2013952","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4134_CR78","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5588\/ijtld.15.0275","volume":"20","author":"HK Yang","year":"2016","unstructured":"Yang HK et al (2016) Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis 20(2):261\u2013264","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04134-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04134-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04134-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:13:14Z","timestamp":1781867594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04134-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4134"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04134-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This manuscript is a narrative review of previously published literature and does not involve human subjects research. IRB review was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"268"}}